Chemical Structure (Auvi Q 01)
Auvi-q Injection, Solution
Product Images NDC 60842-021
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 32 technical images submitted to the FDA as part of the official labeling for Auvi-q (NDC 60842-021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Kaleo, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure A (Auvi Q 02)
The text is describing a device outer case with a viewing window, a red safety guard, a black needle end, and a base.*
Figure B (Auvi Q 03)
Figure C (Auvi Q 04)
Figure D (Auvi Q 05)
Figure E (Auvi Q 06)
Figure A1 (Auvi Q 07)
The text is describing a device or product with an outer casing, possibly used as a safety guard. It appears to include LEDs and a base. The name "TRRINER" is also mentioned, but its significance is not clear.*
Figure A2 (Auvi Q 08)
Figure A3 (Auvi Q 09)
Figure A4 (Auvi Q 10)
Figure A5 (Auvi Q 11)
Figure B (Auvi Q 12)
Figure C (Auvi Q 13)
Figure D (Auvi Q 14)
Figure E (Auvi Q 15)
Figure F (Auvi Q 16)
Figure G (Auvi Q 17)
0.3 mg 2-plus-1 Carton Label (Auvi Q 18)
This is a description of medication packaging and instructions for a product called "Auvi-Q epinephrine injection, USP" which is used for the emergency treatment of severe allergic reactions. The package contains an auto-injector for a single-use injection. The text provides information on the ingredients of the medication, including epinephrine, sodium chloride, sodium bicarbonate, and instructions on how to use the product. It also warns against freezing or refrigerating the medication and instructs to replace the auto-injector if it appears discolored or contains particles. The product is manufactured by kaléo in Richmond, VA.*
0.3 mg Outer Case Label (Auvi Q 19)
This is a medication label for LLL SA6017-01-10 containing epinephrine. The medication should be stored at room temperature and protected from heat, light, and freezing. The acceptable storage temperature is between 68 to 77°F (20 to 25°C) with excursions permitted to 59 to 86°F (15 to 30°C). It is not recommended to use the medication if it is discolored, cloudy, or contains particles. Its manufacturer is kaléo, and their website is www.auvi-g.com.*
0.3 mg Device Label (Auvi Q 20)
This is a set of instructions for using an auto-injector in case of allergic emergencies. The user is instructed to pull down the red safety guard before placing the black end against the outer thigh and pushing firmly for 2 seconds. Medical attention should be sought afterwards. The product is for a single-use injection and the user is advised to refill their prescription after use. There is also information on replacing the protective case and disposing of the used injector safely.*
0.15 mg 2-plus-1 Carton Label (Auvi Q 21)
0.15 mg Outer Case Label (Auvi Q 22)
This is a label for a medication with the NDC number 60842-022-01 and the name "Auvi-Q". The medication is administered through an auto-injector device, and the label provides instructions for storage and use. It warns not to refrigerate or freeze the medication, but rather to store it at room temperature of 68 to 77°F (20 to 25°C). The medication should be protected from heat and light, and excursion up to a range of 59 to 87°F (15 to 30°C) is permitted. After use, the auto-injector device should be discarded. The medication is suitable for individuals weighing between 33 to 66lbs and can be used in the case of allergic emergencies. The label directs users to the instructions on the device for proper usage of the medication.*
0.15 mg Device Label (Auvi Q 23)
Not available.*
Trainer Carton Label (supplied With 0.3 mg And 0.15 mg Auto-injectors) (Auvi Q 24)
This is a description of a training device for use with Auvi-Q, a medical product used for emergency treatment of severe allergic reactions. The Trainer contains no active drug or needle and is only intended to be used for practice to become familiar with the steps to use the actual product. The package includes instructions for use and can be registered online for helpful resources and tools. It is reusable and is not meant to replace the actual emergency treatment product. The Trainer was manufactured by kaleo Inc. in Richmond, Virginia.*
Trainer Outer Case Label (supplied With 0.3 mg And 0.15 mg Auto-injectors) (Auvi Q 25)
This is a description of a TRAINER for practicing how to use an Auvi-Q® device. The TRAINER does not contain active drug or a needle, making it reusable and safe for practice. The device also includes instructions for use and is manufactured by kaléo. There is a website available for registration of refill reminders and other helpful resources. The text also includes some symbols and characters that are not readable.*
Trainer Device Label (supplied With 0.3 mg And 0.15 mg Auto-injectors) (Auvi Q 26)
0.1 mg 2-plus-1 Carton Label (Auvi Q 27)
This is a product description for a single-use injection of epinephrine indicated for allergic emergencies. The package includes a patient information leaflet and trainer instructions, but the trainer does not contain an active drug or needle. Each 0.1 mL contains epinephrine, sodium chloride, sodium bisulfite, and water for injection for patients weighing between 33 and 103 kg. It should be stored at room temperature and not be frozen. The manufacturer is KO Inc., located in Richmond, WA. The text also includes a lot number and a product code.*
0.1 mg Outer Case Label (Auvi Q 28)
This is a description for an epinephrine injection auto-injector for allergic emergencies. The device is for single-use injection for patients weighing between 16.5 Ib to 33 I. The instructions for use are found inside on the device. It is not recommended to refrigerate or freeze the device, instead, it should be stored at room temperature between 68°to 77°F (20°to 25°0); excursions permittedto59° to 86°F (15° to 30°C). Auto-injector should be replaced if the solution appears discolored, cloudy, or contains particles. The device is manufactured for the company kaléo and more information can be found on their website.*
0.1 mg Device Label (Auvi Q 29)
This text appears to be the instructions for using an auto-injector for allergic emergencies. The user is instructed to remove the safety guard, place the black end of the injector against their outer thigh, and hold it there for 2 seconds. The text also advises the user to seek medical attention.*
Trainer Carton Label (supplied With 0.1 mg Auto-injectors) (Auvi Q 30)
This is a trainer for Auvi-q, which contains no active drug or needle. It can be used for practice only and is reusable. The user should read the enclosed trainer instructions for use, and can register for refll eminder and helpful resources at a specific website. It is manufactured by Kaleo, Inc. in Richmond, VA. The also includes some garbled text, so this may not be a complete description.*
Trainer Outer Case Label (supplied With 0.1 mg Auto-injectors) (Auvi Q 31)
This appears to be a description for a Trainer that contains no active drug or needle. There are instructions for use found inside on the Trainer. It is suggested to use this Trainer for practice often. The text also provides a website for helpful resources and tools and for registering for refill reminders. The manufacturer seems to be kaléo and the product's origin is Thailand.*
Trainer Device Label (supplied With 0.1 mg Auto-injectors) (Auvi Q 32)
This text provides instructions for resetting a reusable trainer for practice only. The trainer is for injection training and does not contain any active drug or needle. The instructions describe how to remove and replace the safety guard and where to place the trainer against the outer thigh. The manufacturer of the trainer is Kaleo, Inc. located in Richmond, VA. There is also a mention of replacing the outer case.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
